The Pharmapack Prize jury awarded B. Braun in the “Medical Device” category for the innovative nature of the new Actreen Lite Mini. B. Braun Medical launched in October 2010 the Actreen Lite Mini, its first urinary catheter for intermittent (auto/hetero) catheterization, specifically for women. Actreen® Lite Mini is recommended for chronic urinary retention.
Actreen Lite Mini is a sterile, ready-for-use catheter that can be used without any prior preparation. The special shape from its connector makes the handling easier, even in case of reduced dexterity.
The Actreen Lite Mini catheter was specifically adapted for a woman's urethra. Its length and the distal position of the eyes at its extremity were designed to allow a maximal and safe draining of the bladder. Because of its small size, Actreen Lite Mini is useful and easy to carry. It is available in a 30 pieces box, with individual sterile wrapping and a convenient handling case for daily use, and is available at hospitals, in pharmacies and retailers.
Abbott's sustainable packaging
Pharmapack awarded Abbott Laboratories in the “Sustainable Packaging” category for the innovative nature of the new Kaletra® (lopinavir/Ritonavir) 200mg/50mg, film-coated tablets (lopinavir/ritonavir) packaging.
Since January 2011, the new Kaletra packaging has reduced the pack size by 40% and represents 70% less packaging. It is more compact and provides greater discretion for the patient. The new pack contains 10 blisters of 12 film-coated tablets, i.e. 120 tablets for a 30-day treatment. Each blister represents treatment for three days.
Kaletra has been available since 2001 and is indicated in the treatment of adults and children aged over two years infected with HIV-1, in combination with other antiretroviral agents. Abbott has been committed to the treatment of the HIV infection for more than 25 years and keeps on developing drugs to meet the expectations of healthcare professionals and patients.
Easy-to-use injection device
The “East of Use” Pharmapack award went to Talent BT ™ by Primequal. Talent BT is an injection device for pharmaceutical drug delivery based on an innovative patented “1 Click 1 Dose” technology. Talent BT is an automatic, painless, single-button injection device developed to enable a safer, faster, precise, and repeated dose delivery. For the first time, a step-by-step doser is available in a single-use, disposable, elegant device.
Talent BT has an award-winning design that alleviates patient anxiety and features SmoothJect™, which enables painless injection. The device is made in a way that it cannot be re-opened and cannot be re-filled. When the product to be injected has been expelled, the device locks itself and is then unavailable for a second use. This device therefore offers the highest levels of medical and pharmaceutical safety. Fully adapted to each field of application, Talent BT is designed for the end user to be at ease and comfortable in everyday use.
The 11th edition of Pharmapack will be held on February 15-16, 2012, at la Grande Halle de la Villette, Paris, France.
Actreen Lite Mini is a sterile, ready-for-use catheter that can be used without any prior preparation. The special shape from its connector makes the handling easier, even in case of reduced dexterity.
The Actreen Lite Mini catheter was specifically adapted for a woman's urethra. Its length and the distal position of the eyes at its extremity were designed to allow a maximal and safe draining of the bladder. Because of its small size, Actreen Lite Mini is useful and easy to carry. It is available in a 30 pieces box, with individual sterile wrapping and a convenient handling case for daily use, and is available at hospitals, in pharmacies and retailers.
Abbott's sustainable packaging
Pharmapack awarded Abbott Laboratories in the “Sustainable Packaging” category for the innovative nature of the new Kaletra® (lopinavir/Ritonavir) 200mg/50mg, film-coated tablets (lopinavir/ritonavir) packaging.
Since January 2011, the new Kaletra packaging has reduced the pack size by 40% and represents 70% less packaging. It is more compact and provides greater discretion for the patient. The new pack contains 10 blisters of 12 film-coated tablets, i.e. 120 tablets for a 30-day treatment. Each blister represents treatment for three days.
Kaletra has been available since 2001 and is indicated in the treatment of adults and children aged over two years infected with HIV-1, in combination with other antiretroviral agents. Abbott has been committed to the treatment of the HIV infection for more than 25 years and keeps on developing drugs to meet the expectations of healthcare professionals and patients.
Easy-to-use injection device
The “East of Use” Pharmapack award went to Talent BT ™ by Primequal. Talent BT is an injection device for pharmaceutical drug delivery based on an innovative patented “1 Click 1 Dose” technology. Talent BT is an automatic, painless, single-button injection device developed to enable a safer, faster, precise, and repeated dose delivery. For the first time, a step-by-step doser is available in a single-use, disposable, elegant device.
Talent BT has an award-winning design that alleviates patient anxiety and features SmoothJect™, which enables painless injection. The device is made in a way that it cannot be re-opened and cannot be re-filled. When the product to be injected has been expelled, the device locks itself and is then unavailable for a second use. This device therefore offers the highest levels of medical and pharmaceutical safety. Fully adapted to each field of application, Talent BT is designed for the end user to be at ease and comfortable in everyday use.
The 11th edition of Pharmapack will be held on February 15-16, 2012, at la Grande Halle de la Villette, Paris, France.
